INTRODUCTION
Skeletal muscle is composed predominantly of two major fibre types: slow and fast twitch. The fibre type composition of each muscle determines its physiological capabilities, slow oxidative fibres being required for maintenance of posture and tasks involving stamina, whereas fast glycolytic fibres are required for movements involving strength and speed. These fibre types are defined in large part by the expression of various isoforms of the muscle structural proteins [1, 2] . Fibre specification is achieved at a relatively late stage in skeletal muscle development, and involves a combination of programming in the muscle progenitor cells that gives rise to fibres and a response by fibres to motoneuron contact [3, 4] . Mature skeletal muscle possesses the ability to switch fibre type, termed 'plasticity', in response to changes in innervation status and the sensing of biomechanical load [5] [6] [7] [8] .
There is a substantial body of literature delineating the molecules Abbreviations used: DBD, DNA-binding domain; ECU, extensor carpii ulnaris; EDL, extensor digitorium longus; EOM, extraocular muscle; FCR, flexor carpii radialis; FCU, flexor carpii ulnaris; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RD, repeat domain; GTF2IRD1, GTF2I RD-containing protein 1; HLH, helix-loop-helix; MHC(-I), myosin heavy chain (type I); MLC2 slow , myosin light chain 2 slow; (m/h)MusTRD, (mouse/human) muscle TFII-I RD-containing protein; NLS, nuclear localization signal; RACE, rapid amplification of cDNA ends; RT, reverse transcription; TnI slow , troponin I slow; UTR, untranslated region; WBS, Williams-Beuren Syndrome. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (e-mail ehardeman@cmri.usyd.edu.au). The nucleotide sequence data reported for mMusTRD1α1, mMusTRD3β3, mMusTRD1α4, mMusTRD3α5, mMusTRD1β1, mMusTRD3α7, mMusTRD1β4, mMusTRD3β5, mMusTRD2α5, mMusTRD3β7, mMusTRD3α3 and BEN will appear/have appeared in DDBJ, EMBL, GenBank R and GSDB Nucleotide Sequence Databases under the accession numbers AF497637, AF497641, AF497638, AF497642, AF247161, AF343348, AF497639, AF343350, AF497640, AF343351, AF343349 and AY030287 respectively. and defining their roles in the differentiation and early development of skeletal muscle [9] . Relatively little is known about the mechanisms that determine and maintain skeletal musclefibre types. Recently, the calcineurin [10, 11] and Ras-mitogenactivated protein kinase [12] signalling pathways have been shown to be involved in the maintenance and/or nerve-dependent expression of slow fibre-specific genes in adult muscle.
In order to identify possible regulators that directly control muscle fibre-specific genes, we isolated a novel transcription factor using the enhancer of a representative slow fibre-specific gene, TnI slow (troponin I slow), as bait in a yeast one-hybrid screen of a human skeletal muscle cDNA library [13] . This molecule was named MusTRD1 [muscle TFII-I repeat domain (RD)-containing protein 1], because of its homology with the general transcription factor TFII-I. Both transcription factors contain homologous I-RDs (70 % homology) and a leucine zipper in the extreme N-terminus [14] . In accordance with our hypothesis that MusTRD has a role in regulating the expression of TnI slow , we have shown that MusTRD1 can act as a repressor of the TnI slow enhancer (P. Polly, L. M. Haddadi, L. L. Issa, N. Subramaniam, S. J. Palmer, E. S. E. Tay and E. C. Hardeman, unpublished work).
The human gene encoding MusTRD, GTF2IRD1/WBSCR11/ GTF3 (where GTF2IRD1 is GTF2I RD-containing protein 1), is located on chromosome 7q11.23, a region deleted in the multifactorial neurodegenerative disease, Williams-Beuren Syndrome (WBS) [15] [16] [17] . Patients suffering from WBS display a range of potentially myopathic symptoms, such as an abnormal gait, kyphoscoliosis, joint contractures, muscle weakness, altered muscle fibre size and a low resistance to fatigue [18] . MusTRD's ability to bind an enhancer element within TnI slow , its involvement in regulating this gene's expression and its haploinsufficiency in WBS suggest its involvement in the myopathic aspect of WBS.
There are currently two known human isoforms from this gene, MusTRD1 and a retinoblastoma-associated nuclear protein, Cream1 [19] , that arise from alternative splicing of a 57 bp exon (exon 19) [13] and five mouse isoforms [20] [21] [22] . Recently, an isoform was isolated from Xenopus that appears to be the orthologue of MusTRD1 [23] . Here, we report the identification of 11 mouse (m)MusTRD isoforms isolated from adult and embryonic skeletal muscles. These isoforms arise from the alternative splicing of Gtf2ird1, located on mouse chromosome 5, that involves both single exon and multi-exon cassettes, use of alternative 5 donor and 3 acceptor sites (that are mutually dependent) and alternative 3 terminal exons. In general, these isoforms are expressed ubiquitously in adult and embryonic muscles, but several are subject to spatial regulation. Co-transfection studies of two MusTRD isoforms that differ in their use of alternative C-terminal exons with contractile protein promoters indicate that these isoforms possess differential regulatory capabilities. These differential regulatory capabilities suggest that the MusTRD family of transcription factors have a role in the regulation of multiple muscle-specific promoters.
EXPERIMENTAL

MusTRD antibody
Sheep anti-MusTRD serum was raised against the first 20 amino acids of MusTRD (Mimotopes, Clayton, Victoria, Australia). Hyperimmune serum was affinity-purified using biocytin-tagged N-terminal peptides coupled with M-280 streptavidin Dynabeads (Dynal R , Carlton, Victoria, Australia). Immobilized MusTRD antibody was eluted with 3 M MgCl 2 , pH 7.2. Antibody preparations were dialysed in a buffer containing 25 mM Tris/HCl, pH 7.2, 0.15 M NaCl and 0.1 % (w/v) BSA (TBS-BSA) using Slide-A-Lyzer R Mini Dialysis Units (10 000 MWCO; Pierce, Rockford, IL, U.S.A.). Purified antibody was stored in TBS-BSA with 0.1 % Tween-20 at 4
• C.
Confocal microscopy
Sections (6 µm) of soleus muscle from 8-week-old male B6D2 mice were fixed in 2 % (w/v) buffered paraformaldehyde for 10 min at 4
• C, washed in ice-cold TBS containing 0.2 % Tween-20, then blocked with 10 % donkey serum in TBST for 30 min at 22
• C. Sections were exposed to purified sheep antiMusTRD antibody (1:5 to 1:10 dilutions) in TBST containing 10 % donkey serum overnight at 4
• C, followed by donkey antisheep IgG conjugated to FITC (1:50 dilution) for 1 h at 22
• C (Sigma). Slides were washed and re-labelled with a mixture of mouse anti-dystrophin (DYS2; Novocastra Laboratories, Benton Lane, Newcastle, U.K.) and mouse antibody for myosin heavychain (MHC) type I (MHC-I) (BAF8) [24] 
Rapid amplification of cDNA ends (RACE)
5 RACE PCR was carried out using a mouse skeletal muscle Marathon-Ready cDNA library (Clontech). Oligonucleotides used were the AP1 forward primer (Marathon cDNA Adaptor primer; Clontech) and reverse primer specific to the MusTRD isoforms located downstream of RD2 (5 -GATCCCACTTCTCTG-ACTTGTCATG-3 ). PCR was performed using Advantage HF PCR polymerase mix (Clontech) and MasterAmp PCR Optimization Buffer D (Epicentre Technologies) under the following conditions: 94
• C for 5 s, 72
• C for 4 min for a duration of 5 cycles, 94
• C for 5 s, 70
• C for 5 s, 68
• C for 4 min for a duration of 30 cycles. Southern blotting was used to confirm the presence of MusTRD sequence in the clones. A hMusTRD1 300 bp BamHI probe [13] or a mouse EST clone 555 547 (accession no. AA111609; 4-103 bp) probe labelled with a random primer labelling kit (Giga Prime Labelling Kit; Geneworks) was used. Blots were hybridized overnight at 65
• C in Church buffer and washed at 65 • C in 0.5 × SSC/0.1 % SDS with three changes over 30 min.
RNA isolation
Total RNA was isolated from differentiated C2C12 cultures, adult extraocular muscle (EOM), flexor carpii radialis (FCR), flexor carpii ulnaris (FCU), extensor carpii ulnaris (ECU), plantaris, quadriceps, soleus and extensor digitorium longus (EDL) muscles excised from fifteen 10-week-old female ARC/S mice using the solution D method [25] , whereas total RNA was isolated from the hind-limbs of 20 B6D2 13.5 days post-coitus embryos (E13.5) by Trizol TM (Life Technologies) extraction, according to the manufacturer's instructions.
cDNA synthesis and real-time reverse transcription (RT)-PCR analysis of isoforms cDNA was generated using Im-prompII TM reverse transcriptase (Promega) according to manufacturer's instructions with 2 µg of total RNA as a template. Real-time RT-PCR reactions were carried out using 5 % of the RT reaction as template, 2 × buffer D (Epicentre Technologies) and SYBR R Green. Amplification reactions were established using a series of forward and reverse primers (listed in Table 1 ). Reactions were subjected to an initial denaturation step at 95
• C for 3 min, followed by 35 cycles of 95
• C for 30 s, 60
• C for 1 min and 72
• C for 1 min in a Rotor-Gene TM real-time DNA-amplification system (Corbett Research, Australia). SYBR R Green fluorescence was measured after each extension step. RT-PCR products were subjected to measurement of their annealing temperatures and analysis by gel electrophoresis to verify their specificity and identity. A standard regression curve was drawn for each target mRNA to estimate its relative amount and quantification was derived from the exponential phase of the reaction. PCR products were purified using Qiaquick gel extraction kit (Qiagen) and cloned into pGEM-T Easy vector (Promega). Forward and reverse primers specific for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were designed (Table 1 ) and used as controls to normalize all RT-PCR experiments.
Plasmid constructs for C2C12 transfections
The cDNAs for human h1α1 and mouse isoforms m3α7, m1β1, and m3β7 were subcloned into the AgeI site of the CMV (cytomegalovirus) promoter driven pcDNA3.1 myc/his expression vector (Invitrogen, Sydney, Australia). Reporter plasmid USE-TK-Luciferase contains the hTnI slow upstream enhancer (USE; 157 bp from − 1031 to − 875). (− 3500) βMHC-pGL3 and (− 2554 to + 13) IIβMHC-pGL3 reporters containing regions of the MHC-I gene were kindly provided by Ken Baldwin and colleagues [26, 27] , and the luciferase reporter construct − 800MLC2s was kindly provided by Karyn Esser et al. [28] .
Cell culture and transient transfections
The C2C12 line is a subclone of the mouse skeletal muscle cell line C2 [29, 30] . Monolayer C2C12 cells were maintained in DMEM (Dulbecco's modified Eagle medium) supplemented with 20 % (v/v) fetal-calf serum and 0.5 % chicken embryo extract (both from Gibco BRL) at 37
• C in 10% CO 2 . C2C12 cells were plated at 30-50 % confluence in 24-well plates, cultured for 12 h and then co-transfected using LIPOFECTAMINE TM according to the manufacturer's protocol (Gibco BRL). Plasmid combinations transfected into cells included 100 ng of pcDNA3.1 or pcDNA3.1 containing cDNA for human or mouse isoform expression plasmids, 250 ng of reporter plasmids and 25 ng of RSV-β-galactosidase plasmid as an internal standard. After 6 h incubation at 37
• C in 10% CO 2 , the medium containing the DNA-LIPOFECTAMINE TM mix was removed, and fresh medium supplemented with 2 % horse serum (differentiation medium) was added. After incubation for 36 h in differentiation medium, the cells were lysed and luciferase activity was determined in a TopCount Microplate Scintillation & Luminescence counter (Packard). Values were normalized to β-galactosidase activities. Transfection efficiency varied from 30-40 %. Each experimental condition was measured in triplicate, and the values shown represent the means + − S.D. for three independent experiments. The luciferase activity for each promoter was compared by ANOVA (analysis of variance) and, if found significant, individual comparisons were performed by unpaired t tests. The level of significance was set at P < 0.05.
RESULTS
MusTRD is located in the nuclei of mouse muscle fibres
Transverse sections of an adult soleus muscle were incubated with an anti-MusTRD antibody, which was raised against an N-terminal peptide and should, therefore, recognize all known isoforms. Anti-MHC-I and anti-dystrophin antibodies were coincubated with the anti-MusTRD antibody in order to define fast-and slow-twitch myofibres, and to delineate the position of the muscle fibre plasmalemma. MusTRD proteins could be detected inside muscle fibres, as defined by the ring of dystrophin staining, localizing to the nuclei of both fast and slow muscle fibres ( Figure 1 ).
Isolation, characterization and nomenclature of mMusTRD isoforms
Screening of a mouse skeletal muscle 5 plus stretch λgt11 cDNA library (Clontech) resulted in the isolation of seven different mMusTRD clones, the sequencing of which revealed extensive splicing at the C-termini. 5 RACE PCR on the basis of the conserved 5 end of the cDNAs yielded a product identical with the mouse EST clone BEN (AY030287). RT-PCR was then conducted on mouse adult and embryonic muscles using forward primer 5 UTR (untranslated region) and reverse primers Ex30 and Ex31. Eight different isoforms were identified that differ only in their C-terminal halves. An additional three isoforms were subsequently isolated from differentiated C2C12 myotube RNA, increasing the number of different isoforms to 11. Extensive sequence analysis and alignments mapped all coding sequences to the mouse Gtf2ird1 gene (Figure 2A ). Several of these isoforms (3β7, 3α7, 1α1, 3α5 and 1α4) correspond to isoforms reported by other laboratories [20] [21] [22] , whereas the isoforms 2α5, 3α5, 3β5, 1β1, 1β4, 3α3 and 3β3 are previously unreported.
These isoforms are composed of a conserved N-terminus and a variable C-terminus. The variation in the C-terminus of the protein arises from alternative splicing of four cassettes, in addition to two mutually exclusive C-terminal exons ( Figure 2B ). Two cassettes consist of single exons, 19 and 23, whereas two consist of several exons. The first of these multi-exon cassettes contains exons 21, 22 and 23. The splicing mechanism described for the GTF3 and BEN isoforms [21, 22] shows the second multi-exon cassette containing exons 26-28. However, detailed nucleotide sequence alignment between cDNA and genomic sequences demonstrates unambiguously that this cassette is made up of the 3 region of exon 25, exons 26 and 27 and the 5 region of exon 28 ( Figures 2C  and 2D ). The two mutually exclusive exons, 30 and 31, provide alternative C-termini ( Figure 2C ). MusTRD isoforms contain repeated stretches of amino acids that are highly homologous with one another called RDs. The cassette containing the 3 region of exons 25-27 and the 5 region of exon 28 constitutes the 3 region of RD5 and the 5 region of RD6 ( Figure 2D ). When this cassette is alternatively spliced, the resulting coding sequence contains the 5 end of RD5 and the 3 end of RD6, which forms an RD identical in peptide sequence with that of RD6. The isoforms with either of the multi-exon cassettes alternatively spliced have five RDs, similar to the two hMusTRD isoforms [13, 19] , whereas those with neither alternatively spliced contain six RDs, arranged similarly to those found in TFII-I ( Figure 3A ) [31] . These RDs bear approx. 70 % similarity to those of TFII-I [32] .
Protein motifs in the MusTRD isoforms
A schematic diagram of the 11 mouse MusTRD isoforms is shown in Figure 3 Each RD contains a putative helix-loop-helix (HLH)-like motif that could be involved in homodimerization or heterodimerization. Both TFII-I and MusTRD proteins contain a leucine zipper motif at the extreme N-terminus, also believed to be involved in heterodimerization [33] . In addition, the MusTRDs contain a myc-type HLH motif involved in heterodimerization [34] , and each RD also contains a Leu-Xaa-Xaa-Ile-Leu (LxxIL) motif that is found in most co-activators required for hormone-dependent or -independent nuclear hormone receptor interactions [35, 36] ( Figure 3B ). Interestingly, a unique Ile-Xaa-Xaa-Ile-Ile (IxxII) motif found only in the second RD of MusTRD resembles a core helical motif found in the co-repressors N-CoR and SMRT that is required for nuclear receptor interaction in these proteins [35] . The presence of both types of motifs may allow MusTRD isoforms to play dual roles in the transcriptional regulation of muscle genes. The MusTRDs contain three putative NLSs (nuclear localization signals), one in each of RD2, RD4, and downstream of RD6.
Each isoform contains at least two NLSs, whereas the NLS in RD4 is alternatively spliced, and therefore is absent in isoform m2α5. All isoforms, except for m2α5, contain two DBDs (DNAbinding domains), in RD2 and in RD4 (P. Polly, L. M. Haddadi, L. L. Issa, N. Subramaniam, S. J. Palmer, E. S. E. Tay and E. C. Hardeman, unpublished work). The presence of these NLSs and DBDs is consistent with MusTRD's role as a transcriptional regulator located in the nucleus.
Spatial expression of mMusTRD isoforms
The mMusTRD isoforms contain several RDs that are very similar; in particular, RDs 5 and 6 share identical 5 ends. In isoforms of MusTRD lacking RD5 and containing RDs 4 and 6, the 5 end of RD6 is spliced to the identical region of RD5 ( Figure 2D ). Owing to the extent to which sequences in the 3 region are shared among these isoforms, it is impossible to design primer combinations, cDNA probes or antibodies that exclusively recognize each of the following mMusTRD isoforms m1α1, m1β1, m1α4, m3α5, m3β5, and m3α7. Isoforms m2α5 (lacking RD4), m3α3 (lacking exons 19 and 23, but containing exon 31), m3β3 (lacking exons 19 and 23, but containing exon 30), and m1β4 compared with 3β7 (share exon 23, but can be distinguished from each other by size differences) can be discriminated by RT-PCR.
The presence of these isoforms in various samples representing immature fibres (C 2 C 12 , E13.5 hind-limbs) [37, 38] , and adult head (EOM), forearm (FCR, FCU, ECU) and hind-limb (plantaris, gastrocnemius, quadriceps, soleus, EDL) muscles was determined using RT-PCR (Figure 4 ). Amplification of a region common to all mMusTRD isoforms (0-482 bp) using primers 5 UTR and 482R (Table 1) confirmed that the gene is expressed in all muscle samples tested ( Figure 4A ). The presence of individual isoforms or subsets thereof was examined using specific RT-PCR primer pairs. Using primer Ex19 in combination with Ex30 or Ex31 resulted in the appearance of several closely grouped bands around 1-2 kb ( Figure 4C ) and 1.3 kb (Figure 4D ) respectively. These groups of bands contain α isoforms m1α1, m1α4, m2α5, m3α5 and m3α7 or β isoforms m1β1, m1β4, m3β5 and m3β7 respectively. The presence of each of these isoforms in amplification reactions was confirmed by the cloning and sequencing of several reactions. Primer combinations Ex20/24 [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] that give rise to the 11 mMusTRD isoforms. (D) Cassette 4, which constitutes the 5 region of RD5 and the 3 region of RD6 in isoforms m2α5, m3α3, m3β3, m3α5, m3α7, m3β5 and m3β7, and the exons that form RD6 in isoforms m1α1, m1α4, m1β1 and m1β4 when this cassette is removed by alternative splicing. Colour-coding for the exons is as follows: yellow, exons present in RDs; green, exon 19; red, exon 23; dark blue, exon 27; light blue, polyserine tract; black, NLSs; purple, exon 30; pink, exon 31.
and Ex31, Ex18/20 and Ex31, Ex18/20 and Ex30 were used to specifically amplify isoforms m2α5, m3α3 and m3β3 respectively (shown in Figures 4B, 4E and 4F respectively). Comparison of Figures 4(C) and 4(D) shows that all samples express both α and β isoforms. Although differences are seen in the relative intensity of bands between different samples in each panel, no quantitative conclusions can be drawn from Figure 4 . We conclude from these data that specific isoforms or sets of isoforms are present in each muscle.
In order to provide quantitative assessment of MusTRD isoform expression, real-time RT-PCR reactions were conducted as described in the Experimental section. Expression of total mMusTRD is very high in E13.5 hind-limb and moderately high in EDL, ECU and EOM muscles ( Figure 5A ). However, the expression of individual isoforms does not, in all cases, follow the same pattern as total MusTRD expression ( Figures 5B-5F ).
The relative expression of mMusTRD2α5 in C2C12 cells is comparable with that in EOM, although the total MusTRD expression in EOM is almost 8-fold that of C2C12 (Figures 5A and  5B ). The expression of some of the individual isoforms in the FCR is significantly higher than in the ECU, though the ECU has a far higher expression of total MusTRD (Figures 5A-5F ). Therefore some MusTRD isoforms show a degree of spatial regulation.
Regulation of muscle contractile protein promoters/enhancers by two MusTRD isoforms
In order to test the functional capacity of MusTRD isoforms in skeletal muscle, we compared the ability of four isoforms to regulate three muscle slow fibre-specific promoters/enhancers. Pairs of isoforms were chosen that differ by a single alternative exon at the C-terminus. Expression plasmids encoding h1α1, m1β1, m3α7 or m3β7 were co-transfected with luciferase reporter plasmids containing promoter/enhancer elements from the MHC-I, myosin light chain 2 slow (MLC2 slow ) and TnI slow genes ( Figure 6 ). The core binding motif or Inr-like element (GATTAA) that was defined for 1α1 [13] is present in the MHC-I and TnI slow elements, but not in MLC2 slow . h1α1 repressed both enhancer elements that contain its binding site and did not regulate MLC2 slow . m1β1, which differs from 1α1 by only one exon (30, cf. 31), did not regulate any of the fibre-specific elements. Similarly, isoforms m3α7 and m3β7 were compared. The regulatory capabilities of these two isoforms differed one
Figure 4 RT-PCR analysis of MusTRD isoform expression in skeletal muscle
RT-PCR was performed on RNA isolated from differentiated C2C12 myotubes (C2C12) and mouse 13.5 days post-coitus embryonic hind-limbs (E13.5), adult quadriceps (Quad), soleus, EDL, plantaris, gastrocnemius (Gastroc), FCR, FCU, ECU and EOM muscles and the PCR products were run on agarose gels. Different primer combinations were used to amplify (A) all MusTRD isoforms, (B) m2α5, (C) m1α1, m1α4, m3α5 and m3α7, (D) m1β1, m1β4, 3β5 and m3β7, (E) m3α3, (F) m3β3 and (G) GAPDH.
from the other for each slow fibre-specific element tested. m3β7, but not m3α7, expression significantly repressed MHC-I and m3α7, but not m3β7, significantly repressed TnI slow . m3α7 expression significantly elevated activity from the MLC2 slow enhancer, whereas m3β7 had no significant effect. We conclude that different MusTRD isoforms can elicit different responses from the same gene element. At least one isoform, m3α7, can act in the absence of the cognate MusTRD binding site. In addition, a single isoform of MusTRD is capable of acting as both an activator and a repressor of muscle-specific genes, depending upon the promoter/enhancer, and alternative splicing of a single exon can modify that activity.
DISCUSSION
Structure-function of the mMusTRD family
The MusTRD isoforms are members of a novel gene family that includes the TFII-I family of transcription factors. This family is characterized by a signature arrangement of homologous RDs containing an HLH-like motif, speculated to be involved in protein-protein interactions [14] . The presence of these HLHlike motifs, a leucine zipper and DBDs, in addition to the myc-like HLH motif in MusTRD, implicate these proteins in DNA-protein interactions, as well as multiple interactions with other proteins. Even though motifs may be conserved, it does not mean that they serve the same function in the two gene families. Both MusTRD and TFII-I have a putative leucine zipper at amino acid positions 23-44 in the first RD that may be involved in DNA binding. Cheriyath and Roy [31] have shown that DNA binding by TFII-I requires the first 90 amino acids. In contrast, MusTRD isoforms have two DBDs located in the N-and C-termini between amino acids 408-420 (DBD1) and 738-765 (DBD2) respectively (P. Polly, L. M. Haddadi, L. L. Issa, N. Subramaniam, S. J. Palmer, E. S. E. Tay and E. C. Hardeman, unpublished work).
Figure 5 Real-time RT-PCR analysis of MusTRD isoform expression
Expression of (A) all mMusTRD isoforms, (B) m2α5, (C) 3α5, (D) 3β5, (E) 3α3 and (F) 3β3 was quantified from duplicate RT-PCR reactions performed on RNA isolated from differentiated C2C12 myotubes (C2C12) and mouse 13.5 days post-coitus embryonic hind-limbs (E13.5), adult quadriceps (Quad), soleus, EDL, plantaris, gastrocnemius (Gastroc), FCR, FCU, ECU and EOM muscles. Values are normalized to a GAPDH control and expressed relative to the expression in C2C12 cultures (set at 1). Relative E13.5 levels are plotted against the left y-axis, whereas those from all other sources are plotted against the right y-axis. *P < 0.05.
Although MusTRD and TFII-I share a high level of homology in several regions, alternative splicing patterns bear no similarity in pattern or region. Only two cassette exons are alternatively spliced in TFII-I, exons 'a' and 'b', located between RD1 and RD2. 'Cassette-style' alternative splicing of these exons gives rise to four human isoforms, three homologues of which are present in the mouse [39] . In contrast, the alternative splicing of mMusTRD is far more variable, involving four cassette regions and two mutually exclusive regions, resulting in 11 isoforms present in skeletal muscle alone. The relatively narrow range of physical variation observed in TFII-I compared with MusTRD suggests that these two related transcription factors do not share completely overlapping roles in transcriptional regulation. There are currently two known hMusTRD isoforms, which are 944 amino acids and 959 amino acids in size. The variation between them arises from the alternative splicing of exon 19 [13, 19] , which is also alternatively spliced in the mouse. The identification of 11 mouse MusTRD isoforms with highly variable C-terminal ends suggests that this is a complex family of transcriptional regulators. The m3α7 isoform is identical with BEN1, which was isolated from a brain cDNA library and shown to bind the early enhancer region of the Hoxc8 gene [22] . It has also been shown that the C-terminus of Cream1 is capable of binding retinoblastoma [19] . Together with the data in this manuscript demonstrating differential regulation of muscle fibre-specific genes by MusTRD isoforms, these data support the hypothesis that MusTRD isoforms have multiple roles in transcriptional regulation that is mediated, at least in part, by alternative splicing in the C-terminal half of the molecule.
In addition to facilitating interactions with other proteins, HLH domains have been shown to facilitate interaction between regions of the same protein. This may result in varying tertiary structures between MusTRD isoforms with five RDs and those with six RDs. As well as possible variations in affinity of each isoform for other proteins, these mMusTRD isoforms may also interact with each other, producing a large range of homodimers and/or heterodimers with the ability to recognize a diverse range of DNA motifs. The presence of 11 different isoforms indicates the potential for a wide range of tertiary and quaternary structures with affinity for numerous transcriptional co-regulators and DNA motifs, giving rise to a family with a high level of functional variability. This is supported by the observation that a mutually exclusive alternative splice at the C-terminus can determine the functional capacity of two MusTRD isoforms.
Expression patterns of the mMusTRD family
The classification of MusTRD1/BEN/GTF3/XWBSCR11 as a single, ubiquitously expressed transcription factor in some studies is on the basis of detection methods that recognize multiple, if not all, isoforms from this gene [15, 16, 33, 40] . With the discovery of at least 11 isoforms present in skeletal muscle alone, and with the potential for 24 splice variants in total, it is evident that care must be taken when defining expression patterns and function. We have determined that several individual isoforms (m2α5, m3α3 and m3β3) and groups of these isoforms (m1α1, m1α4, m3α5 and m3α7, and m1β1, m1β4, m3β5 and m3β7) can be discriminated using RT-PCR, but this does not allow unambiguous measurements of each individual isoform. Real-time RT-PCR analysis shows a wide range of total MusTRD expression between different tissues and at different developmental time points. However, this expression profile of different isoforms varies between different muscle samples, such as the EOM and C2C12 cells and FCR and ECU (Figures 5B-5F ). These variations demonstrate that the regulation of expression of individual isoforms is independent of the regulation of total MusTRD expression, because different tissues show differential expression patterns for individual isoforms. Variations in MusTRD isoform regulation between muscles, such as the FCR and ECU, may result from different requirements in controlling fibre type-specific gene expression. However, gene knock-out studies will be required to test whether individual isoforms make specific contributions to the regulation of individual muscle fibre types.
Differential regulation of skeletal muscle gene promoters/enhancers
The four isoforms tested in co-transfection studies had differential regulatory effects on the promoters/enhancers of three muscle slow fibre-specific genes. This study has revealed that the regulatory properties of these isoforms may be due to specific combinations of protein regions, rather than a single signature motif in each isoform. For example, isoform m3α7 stimulates MLC2 slow , whereas m3β7 does not. Since m3α7 differs from m3β7 by the Cterminal exon only, the impact of m3α7 on MLC2 slow expression is due to this single element. Additionally, h1α1 and m1β1 contain the same motifs, except for the C-termini. h1α1 represses the TnI slow enhancer, whereas m1β1 has no effect. In addition, this study has revealed that the sequences present in a specific gene dictate the regulatory capability of a MusTRD isoform. The presence of both IxxIL and IxxII motifs in these isoforms may allow them to behave as both activators and repressors under different circumstances, as seen by the ability of m3α7 to activate MLC2 slow , but repress TnI slow . h1α1 represses MHC-I and TnI slow , but does not regulate MLC2 slow . MHC-I and TnI slow contain the Inr-like element that binds h1α1, and this is absent in MLC2 slow . This provides a means for regulating muscle slow fibre-specific genes independently, as well as in a co-ordinated manner.
Considering the variability in the C-terminal half of these 11 mouse isoforms and in their expression patterns, it is possible that they may have different roles in regulating the expression patterns of various muscle-specific genes and, therefore, in fibre type determination. The fact that they co-exist in different muscles adds to the potential diversity and complexity of their regulatory capacities. Further studies of the effect on gene expression exerted by these isoforms and the biochemical analysis of its protein partners, in addition to knock-out studies, will lead to a greater understanding of the function of MusTRD in regulating gene expression, its role in defining muscle fibre type and potential pathology of its haploinsufficiency in WBS.
Alternative pre-mRNA splicing can create a family of proteins with related, but varying, biochemical properties from a single locus. It is not unexpected, therefore, to find that MusTRD isoforms have differing levels of activity on the target enhancer of TnIslow. Quantitative RT-PCR expression analysis suggests that variations in Gtf2ird1 transcripts do occur between muscle groups. Therefore it is possible that modulation of the MusTRD isoform content within muscle fibres provides a means of differentially regulating downstream target genes in muscles of different fibre composition. It is widely accepted that alternative pre-mRNA splicing is the most important way of achieving greater protein diversity from the surprisingly small numbers of mammalian genes [41, 42] . For the MusTRDs, the extent of isoform complexity could relate to the diversity of genes involving MusTRD regulation and/or the diversity of co-regulatory proteins with which the MusTRDs interact.
